Healthcare Equipment and Supplies
Company Overview of Z-Medica Corporation
Z-Medica Corporation, a medical device company, manufactures and distributes haemostasis agents. It offers sterile nonwoven gauzes, haemostatic bandages, hydrophilic roll dressings, and haemostatic sponges impregnated with kaolin. The company also offers specialty haemostasis products for use in the fields of podiatry, emergency medicine, cardiology, critical care, orthopedics, obstetrics/gynecology, and dermatology. It serves military, first responders, healthcare professionals, law enforcement and emergency response markets, and veterinary markets. Z-Medica Corporation was founded in 2002 and is based in Wallingford, Connecticut.
4 Fairfield Boulevard
Wallingford, CT 06492
Founded in 2002
Key Executives for Z-Medica Corporation
Chief Executive Officer and President
Vice President of Operations
Vice President of International Sales and Business Development
Compensation as of Fiscal Year 2014.
Z-Medica Corporation Key Developments
Z-Medica Corporation Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 07:50 AM
Nov 18 14
Z-Medica Corporation Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 07:50 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Stephen J. Fanning, Chief Executive Officer and President.
Z-Medica Corporation Appoints Stephen J. Fanning as President and Chief Executive Officer
Apr 3 14
Z-Medica Corporation announced that Stephen J. Fanning has been appointed president and chief executive officer of the company. Mr. Fanning joins the company after serving as chairman, president and chief executive officer of publicly traded Solta Medical. Mr. Schillinger is also managing director of DW Healthcare Partners.
Z-Medica Announces Expanded CE Indications for Quikclot Hemostatic Dressings Supporting Broader Use in Surgical Wound Care
Apr 24 13
Z-Medica Corporation announced newly expanded CE indications for QuikClot(R) Hemostatic Dressings. The expanded indications support the use of QuikClot(R) products as an adjunct to manual pressure for the temporary control of moderate external bleeding from surgical wounds or cuts and lacerations during operative and postoperative care. The expanded indications for QuikClot(R) Hemostatic Dressings position these products for use within subcutaneous tissue which will impact how bleeding is controlled in procedures such as cosmetic plastic surgery, breast augmentation and reconstruction, dermatological procedures like Mohs micrographic surgery and punch biopsies, epicardial pacemaker placement, and burn and wound debridement. According to the World Health Organization, there are more than 230 million surgical operations. QuikClot(R) products for hemostasis are now in their third generation and are impregnated with a mineral called kaolin that has been clinically shown to accelerate the body's natural coagulation cascade, without causing any exothermic reaction. Kaolin is a naturally-occurring, inert mineral that does not contain any botanicals or biological material. QuikClot(R) Hemostatic Dressings present many advantages in the surgical setting. They are engineered to be flexible in order to conform to any size or shape wound, and are non-adherent so they can be removed without disturbing the integrity of a clot that has been formed. They also offer easy storage with no need for refrigeration and do not require extensive training to use.
Similar Private Companies By Industry
Recent Private Companies Transactions